Login
+44 203 371 1100
Login
+44 203 371 1100
Credit Sector:- Health Care
Country:- United States
Bond Document:- https://www.bondpdf.com
In order to view the complete data, please login here
| Announcement Date | CA Type | CA Impact | CA Event | ISIN |
|---|---|---|---|---|
| 25-Aug-2015 | Propose Asset Acquisition | - | - | US00214WAE12 |
| Incyte Corporation today announced that it intends to acquire certain real property including land and an office building, located in Wilmington, Delaware from Augustine Land II, L.P. | ||||
| 09-May-2016 | Propose Asset Acquisition | - | - | US00214WAE12 |
| Incyte Corporation today announced that it has entered into a definitive agreement to acquire European operations of ARIAD Pharmaceuticals, Inc. | ||||
| 23-Jan-2017 | Purchase Stock | Target Name | Merus N.V. | US00214WAE12 |
| Incyte Corporation today announced that it has completed the acquisition of 3,200,000 common shares in Merus N.V. | ||||
| 11-May-2016 | Propose Acquisition | Target Name | ARIAD Pharmaceuticals (Luxembourg) S.a.r.l. | US00214WAE12 |
| Incyte Corporation announced today that it has entered into an agreement to acquire all of the outstanding shares of ARIAD Pharmaceuticals (Luxembourg) S.a.r.l. from ARIAD Pharmaceuticals, Inc. | ||||
| 02-Jun-2016 | Asset Acquisition | - | - | US00214WAE12 |
| Incyte Corporation today announced that it has completed the acquisition of European operations of ARIAD Pharmaceuticals, Inc. | ||||
All of the financial data available on this page is sourced from FactEntry.